GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Inventory-to-Revenue

LSL Pharma Group (TSXV:LSL) Inventory-to-Revenue : 1.01 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. LSL Pharma Group's Average Total Inventories for the quarter that ended in Mar. 2024 was C$4.19 Mil. LSL Pharma Group's Revenue for the three months ended in Mar. 2024 was C$4.16 Mil. LSL Pharma Group's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 1.01.

LSL Pharma Group's Inventory-to-Revenue for the quarter that ended in Mar. 2024 declined from Dec. 2023 (1.15) to Dec. 2023 (1.01)

A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. LSL Pharma Group's Days Inventory for the three months ended in Mar. 2024 was 126.73.

Inventory Turnover measures how fast the company turns over its inventory within a year. LSL Pharma Group's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.72.


LSL Pharma Group Inventory-to-Revenue Historical Data

The historical data trend for LSL Pharma Group's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group Inventory-to-Revenue Chart

LSL Pharma Group Annual Data
Trend Sep20 Dec21 Dec22 Dec23
Inventory-to-Revenue
0.34 0.33 0.43 0.35

LSL Pharma Group Quarterly Data
Sep20 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.62 1.89 1.65 1.15 1.01

Competitive Comparison of LSL Pharma Group's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, LSL Pharma Group's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LSL Pharma Group's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, LSL Pharma Group's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where LSL Pharma Group's Inventory-to-Revenue falls into.



LSL Pharma Group Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

LSL Pharma Group's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Inventory-to-Revenue (A: Dec. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )
=( (2.957 + 4.109) / 2 ) / 10.028
=3.533 / 10.028
=0.35

LSL Pharma Group's Inventory-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue (Q: Mar. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Dec. 2023 ) + Total Inventories (Q: Mar. 2024 )) / count ) / Revenue (Q: Mar. 2024 )
=( (4.109 + 4.271) / 2 ) / 4.163
=4.19 / 4.163
=1.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LSL Pharma Group  (TSXV:LSL) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

LSL Pharma Group's Days Inventory for the three months ended in Mar. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2024 )/Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=4.19/3.017*365 / 4
=126.73

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

LSL Pharma Group's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2024 ) / Average Total Inventories (Q: Mar. 2024 )
=3.017 / 4.19
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LSL Pharma Group Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


LSL Pharma Group (TSXV:LSL) Business Description

Traded in Other Exchanges
N/A
Address
3030, Le Carrefour Boulevard, Suite 1002, Laval, QC, CAN, H7T 2P5
Website
LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group (TSXV:LSL) Headlines

No Headlines